research News

A streamlined whole-genome sequencing approach can provide rapid and accurate genomic profiling for acute myeloid leukemia (AML) or myelodysplastic syndromes, according to a study published in the March 11 issue of the New England Journal of Medicine. Eric J. Duncavage, M.D., from the Washington University School of Medicine in St....
ORLANDO – The majority of men who receive one of the standard treatments for localized prostate cancer – surgery or radiation therapy – have an excellent outcome. But for the small group whose prostate cancer returns, a new study offers insight as to why treatment isn’t effective. The study –...
UPTON, NY – Researchers at the U.S. Department of Energy’s (DOE) Brookhaven National Laboratory have demonstrated a new, highly detailed x-ray imaging technique that could be developed into a method for early diagnosis of Alzheimer’s disease. The technique has previously been used to look at tumors in breast tissue and...
XNK Therapeutics will perform a proof of concept study in acute myeloid leukemia (AML) using patient samples from The University of Texas MD Anderson Cancer Center. The proof of concept study is to determine the feasibility to expand and activate NK cells from patients with AML using XNK’s platform. The...